Delivery Order SPE2DR25D1041-SPE2DR26FHR1E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $23,147.47 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on December 15, 2025. This is a firm fixed-price delivery order with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet...
- The Defense Logistics Agency awarded a $19,448.32 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on August 6, 2025, with completion targeted for August 7, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,452.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on November 13, 2025, with completion targeted for November 14, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,927.33 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Zepbound 5 mg/0.5 mL pen injectors, valued at $19,683.15. This is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $6,100.64. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a small-value pharmaceutical procurement executed through the DLA's medical supply chain. The award was made on a competitive basis with no set-aside designation, and the product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,313.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a December 10, 2025 completion date. This contract represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The award was executed on December 9, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $3,614.04 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for Zepbound 5 mg/0.5 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $7,758.90 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injectors on December 12, 2025, with an ultimate completion date of December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply for military healthcare needs. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,396.30 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on November 12, 2025, with an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single line item fulfillment of...
- SPE2DR25D1041Indefinite Delivery Contract
- SPE2DR25D1041-SPE2DR26FHR1EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,529.91 to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a task order executed under a larger Indefinite Delivery Contract vehicle. The award was made on a fully competitive basis with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. This prime contract vehicle supports military healthcare programs globally by enabling the supply of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements has established it as a key pharmaceutical supplier for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.5k | 1/11/26 |